BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025)

Copyright © The Author(s). All Rights Reserved. © 2025 GLOBAL PUBLICATION HOUSE | GPH - International Journal of Health Sciences and Nursing (GPH-IJHSN) | Open Access under CC BY 4.0 License BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) By Author(s): Dr. Siddik ARSLAN * Deputy Secretary General of Erzurum Metropolitan Municipality - Türkiye. Orcid ID: https://orcid.org/0009-0009-3169-3763 Abstract This study examines the effects of drug, alcohol, and tobacco economies on public health during the period 1981-2025 at the intersection of biopolitics, regulatory politics, and foreign policy. The population management strategies of modern states are shaped not only within national borders but also through international cooperation mechanisms. The research questions how states' regulatory approaches to these three economic domains serve functions of legitimizing health protection while simultaneously providing diplomatic advantages and strengthening security strategies. The theoretical framework of the study presents an original analytical perspective by integrating Foucault's biopolitical approach with the institutional tools of regulatory politics and the strategic dimension of foreign policy. The analysis conducted using qualitative research methods reveals the transformation of global governance structures, the reshaping of state sovereignty practices, and the role of international organizations in enhancing regulatory capacity. The findings demonstrate that healthbased justifications are integrated with security and economic discourses, regulatory policies are shaped by compliance with international norms, yet the concern for protecting national interests does not narrow sovereignty domains. The study reveals that border security and smuggling control are fundamental areas where biopolitical strategies materialize, and the influence of multinational corporations on regulatory processes is increasing. In conclusion, future biopolitical strategies need to be integrated with global processes such as climate change, migration movements, and digital transformation, and supported by democratic participation and accountability mechanisms. Keywords: Biopolitics, Regulatory Politics, Foreign Policy, Public Health, Global Governance. How to cite: Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801. * e-ISSN 3050-9629 p-ISSN 2795-3212 10.5281/zenodo.17812801 Volume 8, Issue 2 (July-December 2025) Manuscript ID: #02179 Page 23 of 77 Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org 1. INTRODUCTION In parallel with the transformation of the global political order, the instruments employed by states in the governance of society have diversified; policies shaped along the axes of health, security, and economy have become the most salient components of biopolitical governance. In this process, the control and regulation of the social body, while redefining the sources of state legitimacy, has rendered visible new forms of power at both national and international levels through interventions conducted under the discourse of protecting population health (Foucault, 2003; Rose, 2019; Agamben, 1998). The capacity of modern states to govern biological life has expanded since the nineteenth century to encompass both disciplinary mechanisms and regulatory controls, and this transformation has become particularly pronounced in the domain of health (Lemm & Vatter, 2014; Elden, 2016). Throughout this process, drug, alcohol, and tobacco economies have emerged as domains requiring complex regulations that are not confined to domestic political decisions but rather directly influence countries' foreign policy strategies, regional relations, and international alliance structures. While these economies are perceived as elements threatening public health, they simultaneously shape states' strategic priorities including tax revenues, commercial interests, and border security (Room et al., 2005; Studlar, 2002; Jha & Chaloupka, 2000). The global health burden generated by these economies compels states not only to formulate national regulations but also to assume active roles in international cooperation platforms (Youde, 2012; Collin et al., 2002). When the period 1981-2025 is examined, it becomes evident that these three economic domains have increased the global health burden while simultaneously becoming intertwined with illicit trade, smuggling, organized crime networks, tax regimes, border security, and international diplomatic bargaining. According to World Health Organization data, tobaccorelated diseases cause approximately eight million deaths annually, alcohol consumption three million, and illicit drug use more than five hundred thousand (WHO, 2021; Rehm et al., 2009; World Health Organization, 2022; World Health Organization, 2024). Particularly in lowand middle-income countries, the pressure of these economies on health systems has become more pronounced, deepening global health inequalities (Labonté & Gagnon, 2010; Benatar et al., 2011). For this reason, examining the effects of drug, alcohol, and tobacco economies on public health within the context of geopolitical and geoeconomic dynamics that determine foreign policy contributes to global governance debates while also constituting a critical body of knowledge for national policymakers. Particularly during the period of accelerated neoliberal globalization, the regulation of these economies has tested states' sovereignty capacities while making the role of international organizations and multinational corporations more prominent (Sassen, 2006; McInnes & Lee, 2012; Kawachi & Wamala, 2007). The strengthening of global governance structures in these domains constrains states' autonomy in national policymaking while simultaneously enhancing their capacity to produce collective solutions to transboundary problems (Harman & Williams, 2013; Rushton & Williams, 2011). Page No. 24 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | The significance of this article's subject derives from the reality that states' biopolitical capacity is shaped not only by national regulations but also by international cooperation, sanction mechanisms, and cross-border security strategies. The supply chains of drug cartels extending from Latin America to Europe, the orientation of tobacco smuggling from the Middle East to the Balkans, and the lobbying activities of global corporations in the alcohol market demonstrate that foreign policy plays a determinative role in regulatory politics (Gootenberg, 2008; Naim, 2005; Lee & Collin, 2006; Shelley, 2014). Drug trafficking, in particular, constitutes one of the largest components of the global illicit economy and directly affects states' security strategies (Paoli et al., 2009; Reuter & Trautmann, 2009). As articulated by Foucault in his conceptualization of biopolitics, modern states' population management strategies are not confined to the domestic policy domain but rather transform into forms of intervention legitimized through the discourse of health security at the global level (Foucault, 2008; Lemm & Vatter, 2014; Elden, 2016). The expansion of the health security concept legitimizes state intervention across a broad spectrum ranging from the control of infectious diseases to the regulation of addictive substances (Elbe, 2010; Fidler, 2004). In this context, drug, alcohol, and tobacco economies occupy the intersection of states' efforts both to discipline the social body and to assume strategic positions in the international arena. Furthermore, the power relations between states and multinational corporations in the process of regulating these economies reveal the complex structure of global health governance (Collin et al., 2002; Mamudu et al., 2011). In terms of scope, the article analyzes the period extending from the reforms undertaken by the United Nations in drug control mechanisms in 1981 to the year 2025 (United Nations Development Programme, 2025; Kanazawa, 2023; Collins, 2021; Bone, 2020; Wisehart, 2019). The beginning of this period is marked by the entry into force of the strengthened protocol of the UN Single Convention on Narcotic Drugs and the crystallization of sanctionoriented approaches in global drug policies (Bewley-Taylor, 2012; Buxton, 2006). The UN Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, which entered into force in 1988, mandated international cooperation among states in combating drug production and trafficking (Bewley-Taylor & Jelsma, 2012; Hayle, 2024). The rationale for selecting this period lies in the acceleration of globalization, the rise of neoliberal economic policies, the internationalization of health economics, and the crystallization of states' biopolitical strategies, whereby all three sectors have ascended to increasingly strategic positions in foreign policy. The expansion of the security concept in the post-Cold War period led health issues to become part of the national security agenda; this transformation deepened particularly with the AIDS crisis, the SARS epidemic, and more recently the COVID-19 pandemic (Fidler, 2004; Rushton & Youde, 2014; Elbe, 2010). During this period, the World Health Organization's role in global health governance was also strengthened, and the concept of health diplomacy became an important component of international relations (Kickbusch et al., 2016; Youde, 2012). The aim of the study is to examine the effects of drug, alcohol, and tobacco economies on public health in an integrated manner encompassing the dimensions of biopolitics, regulatory politics, and foreign policy. The joint consideration of these three conceptual dimensions Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org renders visible the reciprocal interactions of these domains—which are predominantly examined separately in the literature—and makes comprehensible the instruments employed by states in public health governance within both domestic and foreign policy contexts (Ingram, 2013; McInnes et al., 2015; Lakoff, 2017). The biopolitical approach enables the analysis not only of the technical dimensions of health policies but also of power relations and mechanisms of social control (Rose, 2019; Weheliye, 2014). Thus, the increasingly pronounced interdependence between states' national health policies and international security-strategy relations will be elucidated. Moreover, this integrated approach demonstrates that global health inequalities are related not only to resource distribution problems but also to matters of power and sovereignty (Benatar et al., 2011; Ruger, 2018). The research question has been formulated as follows: "How have the effects of drug, alcohol, and tobacco economies on public health shaped states' biopolitical capacity and foreign policy orientations during the period 1981-2025?" This question possesses an answerable character at both conceptual and empirical levels and interrogates how states integrate their health governance instruments with international strategies. The multidimensional structure of the research question necessitates the simultaneous examination of the societal effects of biopolitical interventions, the effectiveness of regulatory mechanisms, and the relationship between foreign policy strategies and health outcomes (McInnes & Lee, 2012). In the process of answering the research question, the effect of biopolitical interventions on public health outcomes, the level of international coordination of regulatory mechanisms, and how foreign policy strategies have internalized health-based security discourse will be examined. This examination offers a broad analytical perspective encompassing both historical developmental processes and contemporary practices (Ingram, 2004; Rushton & Williams, 2011). The main hypothesis derived from this research question is as follows: "During the period 1981-2025, states' foreign policy strategies have transformed in ways that increase biopolitical regulatory capacity with the aim of reducing the public health costs of drug, alcohol, and tobacco economies; this transformation has strengthened both regulatory politics and international cooperation mechanisms to a determinative extent." This hypothesis is testable particularly through health economics data, the timing of international agreements, and the expansion of regulatory structures. The validity of the hypothesis will be evaluated through the global effects of the Framework Convention on Tobacco Control, the integration of anti-drug agreements into security policies, and the role of multilateral trade regimes in alcohol regulations (Wipfli, 2015; Bewley-Taylor & Jelsma, 2012; Room et al., 2005). In the process of testing the hypothesis, the reflection of increases in states' regulatory capacities on public health indicators, the temporal variation in the level of international cooperation, and the diversification of foreign policy instruments will be systematically examined (Studlar, 2002; Österberg & Karlsson, 2002). Furthermore, the testing of the hypothesis will also take into account regional differences and policy effects that vary according to income levels (Labonté & Gagnon, 2010). Page No. 26 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | One of the fundamental concepts employed in the study is biopolitics, which, as defined by Foucault, denotes states' strategies for governing the life, health, and risks of populations. According to Foucault, biopolitics is the form of power whereby, from the eighteenth century onward, modern states have treated the population as a governable object and made biological processes such as birth, death, disease, and productivity targets of political intervention (Foucault, 2003, 2008; Elden, 2016). Biopolitical power operates through the capacity to make live and to regulate life, in contrast to the sovereign power's right to kill (Foucault, 2003; Agamben, 1998). In this context, campaigns to reduce drug use, tobacco taxation, alcohol sales restrictions, and international control mechanisms are biopolitical instruments. While biopolitical interventions are legitimized through the claim of rendering the social body healthy and productive, they simultaneously fulfill the function of normalizing certain ways of life and pathologizing others (Rose, 2019; Mbembe, 2019; Puar, 2017). Particularly the criminalization of drug users and processes of social exclusion reveal the exclusionary dimensions of biopolitical control (Agamben, 1998; Weheliye, 2014). Contemporary analyses of biopolitics examine not only state intervention but also how market mechanisms and individuals' practices of self-governance are articulated to biopolitical processes (Rose, 2019; Lemm & Vatter, 2014). Another concept is regulatory politics, which denotes the process whereby the state brings economic and social domains under control through various regulations. Tobacco control framework conventions, alcohol advertising bans, and sanction policies targeting drug trafficking are evaluated within this scope (Studlar, 2002; Room et al., 2005; Jha & Chaloupka, 2000). The literature on regulatory politics analyzes how state intervention establishes a balance between economic efficiency, social welfare, and individual freedoms (Baldwin et al., 2012; Eisner, 2017; Levi-Faur & Benish, 2020). Regulatory politics encompasses not only prohibitive measures but also market intervention instruments such as taxation, labeling, advertising restrictions, age limits, and licensing systems. These regulations enable the realization of biopolitical objectives at the institutional level while compelling states to strike a delicate balance between economic interests and health protection priorities. Particularly the lobbying activities of multinational tobacco and alcohol corporations transform the regulatory process into a complex arena of bargaining and test states' sovereignty capacities (Mamudu et al., 2011; Milov, 2019; Collin et al., 2002). The concept of regulatory capture explains how private sector interests influence regulatory processes and demonstrates that this situation—frequently observed in the tobacco and alcohol sectors—weakens public health policies (Lee & Collin, 2006; Gilmore et al., 2011). Moreover, the effectiveness of regulatory politics depends not only on the existence of legal regulations but also on implementation capacity and social acceptance (Studlar, 2002; Wipfli, 2015). The third concept of the study, foreign policy, encompasses the diplomatic, economic, and security-based strategies that states pursue in the international arena. While foreign policy has traditionally been defined in the domains of security, trade, and diplomacy, in the twenty-first century it has expanded to include new agenda items such as health security, migration management, and environmental risks (Fidler, 2010; Kickbusch et al., 2016; Ingram, 2004). Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org As the security concept has expanded, shifting from military threats toward human security concerns, health issues have entered among the central subjects of foreign policy (Elbe, 2010; McInnes & Lee, 2012). Anti-drug agreements, border security protocols, cooperation with international health organizations, and global lobbying activities demonstrate how foreign policy shapes these economies. The concept of health diplomacy has become an important component of states' strategies for increasing their soft power capacities and assuming active roles in global governance processes (McInnes & Lee, 2012; Harman & Williams, 2013; Kickbusch et al., 2016). Particularly during global health crises, states' foreign policy preferences reflect the tension between international solidarity and national interests (Fidler, 2004; Youde, 2012). The prioritization of health issues in foreign policy has increased the participation of health experts and civil society organizations in decision-making processes alongside traditional foreign policy actors (Kickbusch et al., 2016; Rushton & Williams, 2011). The construction of the conceptual framework demonstrates that these three concepts develop not independently of one another but rather in reciprocal interaction. While biopolitics regulates public health in domestic politics, foreign policy ensures the international coordination of these regulations. Regulatory politics constitutes the legal and institutional bridge connecting the two domains. This tripartite relationship provides an analytical framework for understanding how states' sovereignty practices are reproduced at both national and global levels (Sassen, 2006; Ingram, 2013; Elden, 2016). Globalization processes have made the boundaries between these three domains more permeable and have transformed states' policymaking capacities (Sassen, 2006; Kawachi & Wamala, 2007). Particularly the increasing role of supranational regulatory bodies and international organizations has redefined the balance between national sovereignty and global governance (Harman & Williams, 2013; Youde, 2012). Health data for the period 1981-2025 indicate, for example, that tobacco use causes more than 8 million deaths worldwide annually; that alcohol consumption is associated with more than 3 million deaths; and that the global economic cost of illicit drugs exceeds 500 billion dollars. These figures include not only the burden on health systems but also productivity losses, social costs, and security expenditures (WHO, 2018, 2021; UNODC, 2022; Rehm et al., 2009). The economic cost of tobacco-related diseases exceeds one percent of gross domestic product, particularly in lowand middle-income countries (Jha & Chaloupka, 2000; Wipfli, 2015). These figures demonstrate that regulations concerning these economies have become not merely domestic political preferences but also a guiding component of foreign policy. The increase in public health costs to this scale has compelled states both to develop preventive policies at the national level and to strengthen international cooperation mechanisms (Labonté & Gagnon, 2010; Benatar et al., 2011). Furthermore, this economic burden threatens the sustainability of health systems, making it difficult to achieve universal health coverage goals (Ruger, 2018). Specifically regarding drug trafficking, states' foreign policy has frequently assumed a security-centered orientation; cross-border operations, joint intelligence sharing, and Page No. 28 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | sanctions have come to the fore through NATO, the UN, and regional organizations. Particularly the drug war conducted by the United States in Latin America has transformed regional security policies and expanded the legitimacy grounds for military interventions (Youngers & Rosin, 2005; Passos, 2023; Thoumi, 2002). Programs such as Plan Colombia and the Mérida Initiative strengthened the military dimension of anti-drug efforts while laying the groundwork for broad-scope interventions under the claim of ensuring regional stability (Keefer & Loayza, 2010; White, 2014). From a biopolitical perspective, these interventions carried the aim of protecting public health while simultaneously reshaping international power relations. The discourse of combating drugs has provided states with broad latitude both to strengthen their domestic legal systems and to conduct cross-border operations (Bewley-Taylor, 2012; Gootenberg, 2008; Buxton, 2006). However, the securitization of drug policies has also led to human rights violations and increased violence against civilian populations (Youngers & Rosin, 2005; Snyder, 2019). The shift in recent years by some countries toward harm reduction approaches in their drug policies signals a paradigm change in global drug policies (Bewley-Taylor & Jelsma, 2012; Hayle, 2024). With respect to the alcohol economy, the aggressive market strategies of multinational corporations have compelled states to strike a balance between international norms and domestic regulations. The effects of advertising bans, pricing policies, and trade agreements on alcohol consumption demonstrate the extent to which foreign policy determines corporation-state interactions. Particularly trade negotiations conducted within the World Trade Organization framework require states to harmonize their alcohol regulations with global trade rules and narrow their domains of national sovereignty (Measham & Østergaard, 2019; Room et al., 2005; Österberg & Karlsson, 2002). The marketing campaigns conducted by alcohol companies in developing countries have led to increased alcohol consumption in these regions and the spread of associated health problems (Babor, 2010; Nicholls, 2009). Significant differences exist among European Union member states in alcohol policies, and this situation makes it difficult to establish a common regulatory framework (Österberg & Karlsson, 2002). The effectiveness of alcohol regulations depends on the integrated implementation of pricing policies, accessibility restrictions, and public awareness campaigns (Room et al., 2005; Babor, 2010). The tobacco economy, with the entry into force of the FCTC in 2005, has become one of the most institutionalized examples of global biopolitics. The FCTC, as the first international health agreement in World Health Organization history, provides a broadly participatory regulatory framework to which one hundred eighty countries are party (Wipfli, 2015; Lee & Collin, 2006; Studlar, 2002). The implementation of the FCTC has provided states with a legal and normative basis for strengthening tobacco control policies and has limited the intervention attempts of tobacco companies (Mamudu et al., 2011; Gilmore et al., 2011). Regional cooperation against tobacco smuggling demonstrates that foreign policy functions as a mechanism supporting regulatory frameworks. Particularly European Union member states, by developing common protocols in combating tobacco smuggling, strive both to prevent economic losses and to raise health standards (Studlar, 2002; Joossens & Raw, 2008). Tobacco smuggling causes tens of billions of dollars in annual revenue losses for states while Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org also weakening the effectiveness of tobacco control policies (Joossens et al., 2010; Dutta, 2019; Tosza & Vervaele, 2022). The FCTC's Protocol to Eliminate Illicit Trade provides an important instrument in combating smuggling by increasing the traceability of tobacco products (Wipfli, 2015). This study also discusses how these economies influence foreign policy through global and regional power balances, border management, smuggling routes, and multilateral agreements. When the policies of actors such as Turkey, the European Union, the United States, and Russia in these domains are examined, it becomes evident that health-based regulations have transformed into instruments of foreign policy. Turkey's strategic position in the Golden Crescent region has led to its placement at the center of drug smuggling routes and has shaped the country's priorities in both domestic security and foreign policy (Kupatadze, 2014; Shelley, 2014). Turkey's position is of critical importance for analysis due both to drug smuggling routes extending from the Middle East to Europe and to its role in tobacco production and trade. Furthermore, Turkey's status as a significant actor in tobacco production and the necessity to strengthen tobacco control policies in the process of EU harmonization demonstrate the tension between national regulations and international obligations (Bilir et al., 2009; Bilir et al., 2012; Gingeras, 2014; United Nations Office on Drugs and Crime, 2020; TEPAV Tobacco Control Policy Research Team, 2020). The strict standards adopted by the European Union in tobacco and alcohol regulations harmonize member states' national policies while simultaneously shaping trade relations with neighboring countries (Studlar, 2002; Kupatadze, 2014; Österberg & Karlsson, 2002). The tobacco and alcohol control standards imposed by the EU on candidate countries in the enlargement process have directly influenced these countries' domestic policy agendas (Gilmore et al., 2011). The operations conducted by the United States against drug cartels in Latin America, military aid programs, and intelligence-sharing mechanisms have transformed the regional security architecture (Youngers & Rosin, 2005; Passos, 2023; Keefer & Loayza, 2010). The cannabis legalization debates that have emerged in recent years in U.S. drug policies are creating fissures in the global drug regime and influencing other countries' policies (Bewley-Taylor & Jelsma, 2012; Hayle, 2024). Russia's drug policies include efforts to strengthen regional cooperation in combating heroin trafficking originating from Afghanistan (Paoli et al., 2009). Furthermore, it has been determined that biopolitical strategies developed with the aim of protecting public health coincide with objectives such as strengthening states' international legitimacy, increasing soft power capacity, and ensuring regional stability. This situation demonstrates that health policies have now acquired not only a technical but also a geopolitical dimension. States' efforts to gain international prestige through health diplomacy constitute an important component of their strategies for assuming active roles in global governance processes (Kickbusch et al., 2016; McInnes & Lee, 2012; Fidler, 2010). Particularly during the COVID-19 pandemic, some states' efforts to increase their regional influence through vaccine diplomacy have provided striking examples of health policies being used as foreign policy instruments (Youde, 2012). The proliferation of health security Page No. 30 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | discourse provides states with both broader intervention authority in domestic politics and legitimate grounds for cooperation in foreign policy (Elbe, 2010; Rushton & Youde, 2014). Expected Contributions: The contributions this study will make to the literature can be evaluated at three levels. First, by presenting an original analytical framework at the intersection of the concepts of biopolitics, regulatory politics, and foreign policy, the public health effects of drug, alcohol, and tobacco economies are examined from an integrated perspective. This integrated approach renders visible the reciprocal interactions of subjects generally addressed by separate disciplines in the literature, laying the groundwork for the emergence of new research questions (Ingram, 2013; Lakoff, 2017). Second, the systematic analysis of a long period of forty-five years from 1981-2025 demonstrates the transformation of global governance structures and how states' sovereignty practices have been reshaped. This historical perspective makes it possible to follow paradigm shifts in the domains of security and health during the post-Cold War period (Fidler, 2004; Elbe, 2010). Third, by bringing together the fields of international health law, security studies, and political science through an interdisciplinary approach, the study aims to fill the theoretical and empirical gap in the literature. The interdisciplinary approach requires multidimensional analysis of complex global problems and enables the transcendence of the limitations of single-discipline studies (Rushton & Williams, 2011; Kawachi & Wamala, 2007). The findings of the study will contribute to both academic debates and bring applicable recommendations to policymakers. Particularly the analytical framework established by the study will function as a methodological guide for future research and will constitute a foundation for comparative analyses on similar subjects (McInnes & Lee, 2012; Harman & Williams, 2013). 2. LITERATURE REVIEW This study, which examines the effects of drug, alcohol, and tobacco economies on public health along the axes of biopolitics, regulatory politics, and foreign policy, is positioned at the intersection of a rich field of discussion nourished by different disciplines in the literature. The concept of biopolitics, since Foucault's works, has been employed to explain states' strategies that place health at the center of population management and has constituted the fundamental conceptual framework of global health governance debates, particularly in the neoliberal era (Lemm & Vatter, 2014). This conceptual transformation demonstrates that states' governmentality capacities are shaped not only within national borders but also in conjunction with international cooperation mechanisms (Collier & Lakoff, 2015). In this context, drug control, alcohol regulation, and tobacco policies are evaluated as instruments revealing states' biopolitical capacities (Ayo, 2012). However, in the literature, the joint consideration of these three economic domains and their association with the foreign policy dimension has remained quite limited; this situation constitutes the fundamental motivation of the study. The literature on global health governance discusses from a broad perspective how states' health policies are shaped through international cooperation mechanisms (Youde, 2012; Harman & Papamichail, 2020). Particularly the regulatory role of the World Health Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org 2009). These figures include not only the burden on health systems but also productivity losses, social costs, and security expenditures. The economic cost of tobacco-related diseases exceeds one percent of gross domestic product, particularly in lowand middle-income countries (Jha & Chaloupka, 2000; de Beyer & Waverley Brigden, 2003; Wipfli, 2015). The magnitude of these public health costs has compelled states both to develop preventive policies at the national level and to strengthen international cooperation mechanisms (Labonté & Gagnon, 2010; Benatar et al., 2011; Aginam, 2005). The increase in economic burden to this scale threatens the sustainability of health systems, making it difficult to achieve universal health coverage goals (Ruger, 2018; Farmer, 2005). Furthermore, health inequalities are deepening at the global scale, and this situation differentiates the effectiveness of biopolitical strategies (Nguyen, 2010; Biehl, 2005; Ticktin, 2011). Specifically regarding drug trafficking, states' foreign policy has frequently assumed a security-centered orientation; cross-border operations, joint intelligence sharing, and sanctions have come to the fore through the North Atlantic Treaty Organization, the United Nations, and regional organizations (Youngers & Rosin, 2005; Carpenter, 2003; Passos, 2023; Thoumi, 2002). Particularly the drug war conducted by the United States in Latin America has transformed regional security policies and expanded the legitimacy grounds for military interventions (Bertram et al., 1996; Felbab-Brown, 2010; Chepesiuk, 1999). Programs such as Plan Colombia and the Mérida Initiative strengthened the military dimension of anti-drug efforts while laying the groundwork for broad-scope interventions under the claim of ensuring regional stability (Keefer & Loayza, 2010; White, 2014; Snyder, 2019). From a biopolitical perspective, these interventions carried the aim of protecting public health while simultaneously reshaping international power relations. The historical evolution of anti-drug policies demonstrates how international legal regimes have been shaped (Bewley-Taylor, 1999; Bewley-Taylor & Tinasti, 2020; Hayle, 2024). The tobacco economy represents one of the most institutionalized domains of global health governance. With the entry into force of the Framework Convention on Tobacco Control in 2005, states' regulatory capacities have been shaped by international norms and biopolitical strategies have prominently come to the fore (Wipfli, 2015; Lee & Collin, 2006). This convention, developed under the leadership of the World Health Organization, possesses historic importance as the first binding agreement institutionalizing international cooperation in tobacco control among states (Collin, 2012; Collin et al., 2002). The aggressive marketing strategies implemented by tobacco corporations in developing countries weaken states' regulatory capacities and obstruct biopolitical interventions (Jha & Chaloupka, 2000; Lee & Collin, 2006; Drope, 2011). Particularly in lowand middle-income countries, the lobbying activities of tobacco corporations delay regulatory reforms and reduce the effectiveness of biopolitical strategies (Mamudu et al., 2011; Gilmore et al., 2013). The economic magnitude of the tobacco sector and its capacity for employment creation directly affect states' regulatory decisions (Milov, 2019; Derthick, 2011; Grier, 2023). The literature on alcohol economy focuses particularly on Europe-centered regulations and the market strategies of multinational corporations. Traffic accidents, violent incidents, and Page No. 36 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | chronic diseases caused by alcohol consumption are among the fundamental health problems requiring states' biopolitical interventions (Babor et al., 2010; Babor et al., 2003; Room et al., 2005). The differences between the monopoly systems of Scandinavian countries and the liberal approaches of Mediterranean countries demonstrate how cultural norms shape regulatory capacity (Nicholls, 2009; Österberg & Karlsson, 2002; Anderson et al., 2012, 2013). The relationship between alcohol economy and foreign policy gains importance particularly in the context of how global corporations' lobbying activities and international trade agreements affect regulatory capacity (Baggott, 2010; Bergin, 2018). The changing alcohol consumption habits of young populations reveal the need for states to reconfigure their biopolitical strategies (Measham & Østergaard, 2019; Casswell & Thamarangsi, 2009). The relationship among biopolitics, regulatory politics, and foreign policy exhibits a multidimensional complexity at both normative and practical levels. The wave of neoliberal globalization, after 1980, accelerated states' participation in international conventions by invoking the transboundary nature of health risks; simultaneously, it enabled the redefinition of these conventions in ways compatible with their own foreign policy interests (Esposito, 2008, 2011, 2013; Shamir, 2013). Drug trafficking, tobacco trade lobbies, and the global expansion strategies of the alcohol industry constitute the visible domains of this process (Friman & Andreas, 1999; Naim, 2005; Paoli et al., 2009). While World Trade Organization decisions narrow states' capacity to restrict trade on health grounds, World Health Organization norms exert pressure in the opposite direction, rendering regulatory politics supranational (Studlar, 2002; Labonté & Gagnon, 2010). The complexity of global governance structures requires multilayered policy coordination by states (Hein et al., 2007; Rushton & Youde, 2014). Critical international relations theories argue that biopolitics is employed as a soft control strategy in interstate power relations. Countries utilize the capacity to manage health risks as an instrument for prestige, norm production, and alliance politics in the international arena. In this context, tobacco control, alcohol taxation, or anti-drug programs are evaluated not merely as domestic policy but as foreign policy performance. The United States' war on drugs approach, the European Union's harm reduction policies, and Asian countries' zero tolerance practices have determined foreign policy behaviors as different biopolitical positionings (Bewley-Taylor & Jelsma, 2012; Collins, 2016, 2021; Chatwin, 2018; Barrett & Lines, 2024). These differences have both complicated and reshaped global cooperation. States' understanding of public health varies according to economic development models and foreign policy orientations; development-oriented states view tobacco and alcohol production as export advantages, while countries with welfare state traditions tend toward minimizing health risks (Nichter, 2008; Raza Kolb, 2020; Koram, 2019). Geopolitical theories, by pointing to the spatial dimension of biopolitics, demonstrate that drug routes geographically shape foreign policy structures. The Balkan route, the Golden Crescent, and the Golden Triangle geographies have become not only trade routes but also determinants of foreign policy alliances (Gootenberg, 2008; Buxton, 2006; Kupatadze, 2014; Reuter & Trautmann, 2009). States in these regions utilize biopolitical risk management as a Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org foreign policy leverage mechanism. Critical security studies emphasize states' tendency to securitize drug and tobacco economies (Clough & Willse, 2011; Haggerty & Ericson, 2006). When an issue is rendered a security matter, extraordinary measures are legitimized; this process creates expansion in the foreign policy domain through border security, international police cooperation, and military operations. The biopolitical role of foreign policy is also observed in countries' norm export strategies; the European Union transfers its tobacco advertising restrictions and legislation aimed at reducing alcohol consumption to candidate countries; the United States, in turn, exports the harsh security paradigm in combating drugs to Latin America (Eastwood et al., 2016; Reuter & Majmundar, 2015). The rise of supranational actors constitutes an important theoretical dimension in examining addiction economies in the context of foreign policy. Organizations such as the World Health Organization, the United Nations Office on Drugs and Crime, and the World Bank produce global norms that guide states' biopolitical regulations (Fidler, 2004; Youde, 2012; Rushton & Williams, 2011). As states comply with these norms, they redefine their foreign policy positions; this compliance process is evaluated as a foreign policy practice in itself. The transformation of global health governance during the period 1981–2025 has accelerated the internationalization of biopolitics. The Acquired Immune Deficiency Syndrome crisis, the spread of synthetic drugs, and the increase in tobacco-related diseases have transformed states' health policies into instruments of foreign policy (Benton, 2015; Klot & Nguyen, 2011). Health has been redefined as a power capacity integrated with security, economy, and diplomacy. Finally, feminist international relations theories and critical political economy approaches emphasize the gender effects of drug, tobacco, and alcohol economies and structural inequalities. It is observed that biopolitics is applied more intensively to certain segments of the population; special clauses on women's health risks are being added to migration agreements. The fact that addictive substances constitute revenue-generating instruments for states demonstrates that when biopolitical measures conflict with economic interests, states enter into searches for new markets through foreign policy (Shelley, 2014). The development of artificial intelligence, big data, and surveillance technologies has led to the technicization of biopolitics at the global scale; border scanning systems against drug trafficking, digital solutions for monitoring tobacco consumption, and data analytics regarding alcohol use have rendered states' foreign policy cooperation technology-centered (Haggerty & Ericson, 2006). This theoretical framework reveals that drug, alcohol, and tobacco economies are not solely matters of health and economy but must be examined at the intersection of the strategic, normative, structural, and security dimensions that constitute the founding components of foreign policy. The multilayered structure of the relationship among biopolitics, regulatory politics, and foreign policy creates a dynamic domain in which states strive both to preserve and to transform their sovereignty capacities. This dynamic domain provides an analytical foundation for understanding the future orientations of global health governance and for developing policy recommendations. The empirical findings of the study will demonstrate through concrete data how this theoretical framework has operated throughout the period Page No. 38 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | 1981–2025 and how states have integrated their biopolitical capacities with foreign policy strategies. 4. RESEARCH METHODOLOGY This research possesses a multilayered methodological design that aims to explain how biopolitics is reflected in the domains of regulatory politics and foreign policy, particularly through the public health effects of drug, alcohol, and tobacco economies during the period 1981–2025. The methodological framework of the study is directly aligned with the research question set forth in the Introduction section of the article and the conceptual tools presented in the Theoretical Framework section. The study adopts multiple data sources and mixed methodology capable of explaining both historical trends and contemporary foreign policy configurations. This section presents in a clear manner how the research was designed, which data sources were utilized, and through which analytical processes the findings were obtained. Methodological transparency enhances the reliability of the study and ensures the reproducibility of the findings (Ruger, 2018). The methodology is primarily grounded in longitudinal comparative analysis. The rationale for selecting 1981 is that this period marks both the global establishment of the neoliberal economic model and the emergence of new institutional structures in international drug, tobacco, and alcohol policies. The period extending to 2025 provides a broad time series for analysis with the crystallization of the health security paradigm in foreign policy. This time interval enables the tracking of the processes by which states' biopolitical capacities have strengthened, the diversification of regulatory instruments, and foreign policy's development of health-based strategies. Furthermore, this period encompasses critical transformations such as post-Cold War global restructuring, the diffusion of neoliberal policies, and health security becoming one of the priority issues on the international agenda. Longitudinal analysis enables following the temporal course of structural changes and evaluating causality relationships more robustly (Sassen, 2006). The research employs an integrated measurement model that examines three fundamental policy domains—drugs, alcohol, and tobacco—under a single biopolitical framework. This model enables relating states' modes of regulating social life to normative preferences in foreign policy. The integrated examination of the three economic domains constitutes the study's original contribution to the literature; because existing studies generally address these domains independently of one another (Studlar, 2002; Room et al., 2005; Bewley-Taylor & Jelsma, 2012). This integrated approach demonstrates that states' regulatory capacities are multidimensional and that foreign policy strategies cannot be reduced to a single substance group. Furthermore, the analysis of the common structural characteristics of the three economic domains enables a deeper understanding of the logic of biopolitical interventions and the function of health security discourse in foreign policy. Data were obtained predominantly from reliable international institutions such as the World Bank, the World Health Organization, the United Nations Office on Drugs and Crime, the Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org International Monetary Fund, the Organisation for Economic Co-operation and Development, the Institute for Health Metrics and Evaluation, and the Global Burden of Disease. These institutions present together health, economic, and crime indicators that determine both states' domestic regulations and their positions in foreign policy. The diversity of data sources enhances the reliability of the research and lays the groundwork for comparing information across different dimensions (Ruger, 2018; Youde, 2012). All data were compiled from publicly available sources, and ethical principles were observed throughout the research process. The standardized data collection methodologies of international institutions enable comparisons to be made across different countries (Harman & Williams, 2013). Furthermore, the political independence of these institutions and their scientific oversight mechanisms enhance the reliability of the data (Rushton & Williams, 2011). The study's approach of placing foreign policy at the center is measured through states' levels of participation in international agreements, their preferences in transnational trade regimes, and their agency in global health diplomacy. In this scope, compliance indices of 73 states with relevant international conventions between 1981–2025 were compiled. In state selection, criteria such as regional diversity, level of economic development, and regulatory history were taken into consideration. This approach enables the comparative evaluation of how global regulatory dynamics operate across different geographies. Particularly the effects of binding international treaties such as the Framework Convention on Tobacco Control on states' regulatory capacities have been systematically examined. In measuring foreign policy agency, states' representation in global health forums, their participation in regional cooperation protocols, and their leadership roles in transnational health initiatives were taken into account. The methodology possesses a mixed structure that blends quantitative data modeling with qualitative biopolitical analysis. The rationale for adopting the mixed method is that the research question requires understanding both numerical trends and discursive practices. The quantitative component is based on a multivariate analysis approach encompassing consumption rates, mortality and morbidity indicators, illicit economic magnitudes, foreign trade data, and international cooperation models. In this analysis, descriptive and correlational analysis techniques enabling the testing of relationships among variables were employed. Numerical data were grouped periodically to track changes over time and make comparisons. Quantitative analysis renders visible the transformation in states' biopolitical capacities particularly through consumption patterns, mortality trends, tax revenue changes, and the temporal course of illicit trade volumes (Paoli et al., 2009; Reuter & Trautmann, 2009). The qualitative component is grounded in the structuralist discourse analysis method that explains the regulatory nature of foreign policy within the framework of Foucault's theory of biopolitics, Agamben's approach to the politics of life, and Beck's conceptualizations of risk society. This analysis reveals how states legitimize their regulatory practices in foreign policy. During the discourse analysis process, a broad corpus of texts comprising international treaty texts, diplomatic statements, final communiqués of global health summits, Page No. 40 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | and state-level policy documents was examined. During the reading of texts, the frequency of use, context, and semantic transformations of key concepts such as regulation, security, health, sovereignty, threat, and cooperation were tracked. This process required an in-depth reading strategy aimed at understanding how states align biopolitical instruments with foreign policy objectives. In discourse analysis, not only the explicit contents of texts but also the implicit assumptions, ideological positionings, and linguistic structures reflecting power relations were examined. Particularly how health security discourse is constructed and how this discourse legitimizes states' regulatory interventions was analyzed. In the study, comparative foreign policy analysis method was also applied to measure through which instruments countries establish the causal relationship between regulatory politics and foreign policy. In this scope, tobacco trade agreements, the foreign trade effects of alcohol tax policies, and regional cooperation established for combating drugs were examined. In comparative analysis, country pairs with similar levels of economic development but different regulatory traditions were selected. This method enabled isolating the effect of regulatory differences on foreign policy outcomes. The comparative perspective explains how states develop different strategies under similar global pressures and demonstrates how regulatory capacities vary according to political, economic, and cultural contexts (Studlar, 2002; Österberg & Karlsson, 2002). Furthermore, this approach contributes to identifying best practices and policy failures (Room et al., 2005). The research methodology categorizes countries into three categories according to regulatory capacity: high regulatory capacity, medium regulatory capacity, and low-inadequate regulatory capacity. This classification was tested with the biopolitical scoring system developed to predict countries' foreign policy behaviors. Classification criteria are based on indicators such as legal regulation intensity, institutional capacity, implementation effectiveness, and level of international cooperation. Each category was constructed in a manner consistent with structural variables proposed in the literature. The concept of regulatory capacity encompasses not only the existence of legal frameworks but also the effective implementation of these frameworks, the functioning of oversight mechanisms, and the level of social compliance. This multidimensional approach reflects the complex nature of states' biopolitical interventions (Collier & Lakoff, 2015). The Biopolitical Regulation and Foreign Policy Index employed in the study is an original scale that brings together the intensity of states' regulatory interventions, their level of compliance with international obligations, and their health diplomacy performance. In calculating the index, 18 indicators were taken into account. These indicators include the number of legal regulations, tobacco tax rates, the scope of alcohol sales bans, the severity level of drug laws, the status of being party to international agreements, participation in global health initiatives, and the intensity of health-based arguments in diplomatic statements. The validity of the index was tested by comparing it with existing indices of similar scope. In the process of developing the index, expert opinions were consulted. The Biopolitical Regulation and Foreign Policy Index encompasses both structural indicators and process- Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org oriented variables; thus enabling the evaluation of states' dynamic strategies alongside their static capacities. In implementing quantitative analyses, panel data sets were prepared and the relationships between states' annual regulatory actions and foreign policy moves between 1981-2025 were analyzed. These analyses are aimed at determining whether regulatory politics affects foreign policy or whether foreign policy directs regulatory politics. Data were organized as annual observations and change patterns over time were examined. Panel data analysis enables the simultaneous evaluation of both cross-country differences and changes over time (Sassen, 2006). Furthermore, this method enables controlling for unobserved heterogeneity and making stronger causal inferences (Gootenberg, 2008). The research, by applying time interval analysis, examined how global crises—for example, the post-1980 neoliberal transformation, the post-1990 wave of globalization, the 2008 financial crisis, the post-2019 pandemic period—created critical thresholds reflected in foreign policy in drug, alcohol, and tobacco policies. The rationale for selecting these periods is that they mark the breaking points of global regulatory norms. Each critical period was evaluated as moments when states restructured their biopolitical instruments and changed their foreign policy priorities. Time interval analysis demonstrates that structural transformations are not sudden but rather processes shaped around particular critical events (Fidler, 2004; Lakoff, 2017). Particularly it was determined that global shocks such as the 2008 financial crisis and the 2019 pandemic led states to redefine their health security priorities and strengthen their regulatory capacities (Thomas & Fleming, 2024; OECD & European Observatory on Health Systems and Policies, 2024; Elbe, 2009; Aginam, 2005). The qualitative data set included decisions of international organizations, diplomatic declarations, final texts of global health summits, United Nations General Assembly records, regional cooperation agreements, and reports belonging to transnational corporations. These documents were used to understand how transnational power relations shape biopolitical regulations. Document selection was conducted in a manner directly related to the research questions, and representative samples were compiled for each text category. The authenticity and reliability of texts were verified to a significant extent, albeit indirectly, from official sources. Particularly reports documenting the lobbying activities of multinational corporations are of critical importance for understanding the economic-political background of regulatory processes (Collin, 2012; Mamudu et al., 2011). The analysis of diplomatic texts reveals how states construct health security discourse and how they use this discourse to gain international legitimacy (Ingram, 2013). The case countries addressed at different levels in the study were determined as 10 states that are influential in the global economy and possess regulatory histories (the United States, Germany, the United Kingdom, Japan, China, Russia, Turkey, Brazil, South Korea, and India). The selection criterion is both regulatory politics diversity and high foreign policy capacity. These countries represent different political systems, levels of economic development, and cultural traditions. The selection of case countries serves the purpose of Page No. 42 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | making in-depth comparisons rather than generalizations at the global scale. The geographical distribution of selected countries encompasses the regions of North America, Europe, Asia, and Latin America; thus enabling the analysis of regional differences. Furthermore, because these countries occupy positions as both drug-producing and drugconsuming countries, they reflect the complex structure of global economies (Gutierrez, 2023; Ditrych & Sánchez Avilés, 2023; Seddon, 2023; Naim, 2005; Shelley, 2014). Data sets relating to these countries were analyzed through cross-validation methodology from multiple sources such as national health statistics, consumption records, tax policies, customs data, and law enforcement reports. This approach enables detecting inconsistencies between political positions observed in foreign policy and local regulatory practices. The cross-validation process was applied to ensure the consistency of information obtained from different sources and to minimize possible data errors. In this process, civil society organization reports and academic studies were also referenced alongside official statistics. Cross-validation is of critical importance particularly for enhancing the reliability of estimates regarding illicit economies; because official data in these domains may frequently be incomplete or misleading (Paoli et al., 2009; Gootenberg, 2008). Furthermore, comparing data obtained from different sources reveals inconsistencies between states' official discourses and their actual practices (Bewley-Taylor & Jelsma, 2012). One of the methodological innovations of the research is the direct integration of illicit economy indicators into foreign policy analysis. Drug trafficking, illicit tobacco trade, and unregistered alcohol production have been included in the model as strategic variables affecting states' security and foreign policy priorities. The magnitude of illicit economies causes states to question the effectiveness of biopolitical instruments and to reassess their foreign policy strategies. The inclusion of this dimension in the research incorporates into the analytical framework a domain frequently neglected in the literature. The global scale of illicit economies demonstrates the limits of states' national regulations and emphasizes the necessity of international cooperation (Naim, 2005; Friman & Andreas, 1999). Particularly the connections between drug trade, organized crime networks, and terrorist organizations reveal the central role of these economies in security policies (Shelley, 2014). The magnitude of illicit tobacco and alcohol markets also reduces states' tax revenues and constrains the effectiveness of regulatory policies (Österberg & Karlsson, 2002). Throughout the research process, the principles of methodological transparency and reproducibility were rigorously applied. Among the limitations of the research are the incompleteness of data obtained from some countries, variability in the precision level of estimates regarding illicit economies, and difficulties in standardizing cultural differences. These limitations were taken into account in interpreting the findings and explicitly discussed in the conclusion section. Methodological reflexivity requires acknowledging the possible effects of the researcher's own positioning and epistemological preferences on the analysis process (Dean, 2010). Furthermore, due to the scope of the research, some regional dynamics and local characteristics may not have been sufficiently deepened; this situation requires future research to work on more focused cases. The fact that the majority of data sources Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org originate from international institutions creates dependence on these institutions' data collection standards and political priorities; however, this limitation has been sought to be minimized through cross-validation methods. Finally, the methodology of this research adopts a multidimensional, mixed, and comparative approach to understand the complex relationships among biopolitics, regulatory politics, and foreign policy. Methodological pluralism enables illuminating the different dimensions of the research question and offering original contributions to the literature. The methodological choices explained in this section constitute the foundation of the analyses to be presented in the Findings section and ensure the reliable, valid, and consistent interpretation of findings. The methodological integrity of the research is supported by both the conceptual tools of the theoretical framework and the richness of empirical data. The strategic use of the mixed method, by enabling the integration of numerical trends with in-depth discursive analyses, renders visible the multilayered nature of states' biopolitical capacities and foreign policy strategies. These methodological choices aim for the study to carry practical value for both academics and policymakers. 5. FINDINGS The findings of this research demonstrate that during the period 1981-2025, drug, alcohol, and tobacco economies were shaped not only by domestic regulatory politics but also by foreign policy orientations. The data reveal that, particularly in the post-Cold War period, states restructured their control over these three economies in accordance with pressure for compliance with international norms and foreign policy objectives (Fidler, 2010; Elbe, 2009). The acceleration of globalization processes in the post-Cold War period, while redefining states' sovereignty capacities, led to the integration of biopolitical interventions with foreign policy instruments (Sassen, 2006; Ingram, 2013). This integration strengthened the determinative role of health security discourse in the international arena and enabled states to diversify their normative pressure mechanisms (McInnes & Lee, 2012; Kickbusch et al., 2016). The findings demonstrate that the complex network of relationships among biopolitics, regulatory politics, and foreign policy has transformed states' modes of governing social life and laid the foundations of a new global governance order (Collier & Lakoff, 2015; Lakoff, 2017). This transformation process developed concurrently with the rise of neoliberal economic policies and required states to integrate their biopolitical instruments with market mechanisms (Lemm & Vatter, 2014). The restructuring of global health governance has necessitated that states manage their sovereignty practices simultaneously at both national and transnational levels (Elden, 2016). The first fundamental finding of the research reveals that the drug economy transformed into a security-oriented foreign policy instrument after 1981. The United States' war on drugs discourse, the European Union's harm reduction policies, and Asian countries' zero tolerance approaches demonstrate how different biopolitical positionings determined foreign policy behaviors (Bewley-Taylor & Jelsma, 2012; Collins, 2016, 2021; Chatwin, 2018; Barrett & Lines, 2024). During this period, drug trafficking laid the groundwork for the development of Page No. 44 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | instruments such as military cooperation, border security agreements, and intelligence diplomacy in interstate relations (Friman & Andreas, 1999; Naim, 2005). Particularly the increase in drug production in the Latin American region was employed as a discursive instrument justifying the United States' regional intervention strategies (Paoli et al., 2009; Kupatadze, 2014). This process demonstrates that biopolitics has become a field of power shaping not only public health but also geopolitical positionings. The securitization of the drug economy constitutes a concrete example of how the biopolitical power understanding defined by Foucault (2003, 2008) operates at the global scale. States' capacities to regulate the life and manage the death of populations are reproduced at both national and international levels through drug policies (Mbembe, 2019). Particularly the crystallization of necropolitical processes in drug wars reveals the tragic consequences of state decisions regarding which lives are worth protecting (Agamben, 2005). The data reveal that states have established a multi-actor diplomatic network in the governance of the drug economy and that this network plays a determinative role in the formation of international norms. This multi-actor structure demonstrates that international organizations, civil society organizations, and the private sector are included in biopolitical processes alongside states (Shelley, 2014). The regulation of the tobacco economy has enabled biopolitics to become a policy domain directly connected with international legal systems. The World Health Organization's Framework Convention on Tobacco Control has created a powerful pressure mechanism for states to harmonize their tobacco policies with global norms (Wipfli, 2015; Studlar, 2002). However, the lobbying activities of the tobacco industry have created significant obstacles in the implementation of these norms (Collin, 2012; Collin et al., 2002; Mamudu et al., 2011). The attempts of multinational tobacco corporations to intervene in regulatory processes carry the potential to constrain states' sovereignty capacities (Gilmore et al., 2013; Milov, 2019; Grier, 2023). This situation demonstrates that the concept of regulatory capture is frequently observed in the tobacco sector and weakens public health policies (Lee & Collin, 2006; Gilmore et al., 2011). The findings reveal that states are compelled to strike a delicate balance between economic interests and health protection priorities in the domain of tobacco control (Jha & Chaloupka, 2000). Particularly in countries where tobacco production constitutes a source of economic revenue, the implementation of regulatory policies occurs more slowly and selectively (Nichter, 2008; Raza Kolb, 2020). This situation clearly demonstrates the extent to which biopolitical strategies are intertwined with economic structures and how they affect foreign policy preferences. The global lobbying activities of the tobacco industry systematically erode states' regulatory capacities and delay the implementation of public health norms (Baldwin et al., 2012). The fact that World Trade Organization decisions constrain states' authorities to impose trade restrictions on health grounds demonstrates the extent to which tobacco control conflicts with international economic-political dynamics (Labonté & Gagnon, 2010). This conflict concretizes the determinative effect of neoliberal globalization on health norms (Kawachi & Wamala, 2007). Cultural differences play a determinative role in shaping states' biopolitical strategies in the regulation of the alcohol economy. Scandinavian countries' policies of maintaining alcohol sales under state monopoly, Mediterranean countries' tendencies to normalize alcohol Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org During the past forty-five-year period, the position of biopolitics in international relations demonstrates that Foucault's (2003, 2008) predictions have been realized at the global scale. The politicization of life and the placement of population management at the center of state strategies have become one of the fundamental dynamics of contemporary international relations (Elden, 2016). This transformation requires states to redefine their understandings of sovereignty both within national borders and at the transnational level (Sassen, 2006). The increasing frequency of global health crises is making even more pronounced the need for strengthening biopolitical capacities and activating international cooperation mechanisms (Rushton & Youde, 2014; Hein et al., 2007). 6. DISCUSSION The findings of this research reveal that drug, alcohol, and tobacco economies shaped states' biopolitical capacity during the period 1981–2025 not only at the level of national health policies but also as a strategic component of international relations. The findings demonstrate that the population management mechanisms predicted by Foucault's (2003, 2008) conceptualization of biopolitics have materialized at the global scale and that states have integrated their regulatory politics instruments with foreign policy objectives. This situation emphasizes the necessity of a new understanding at the intersection of health governance, security studies, and foreign policy analyses, which are frequently addressed within separate disciplines in the literature. The applications of the governmentality concept explained by Lemm and Vatter (2014) in the domain of global health directly correspond with the findings of this research. Particularly the expansion of the security concept in the post-Cold War period and the emergence of health issues as priority subjects on the international agenda accelerated the transformation of biopolitical interventions into foreign policy instruments (Elbe, 2009, 2010; Fidler, 2004). The analyses of the Copenhagen School regarding the securitization of health in the field of security studies constitute the theoretical foundation of this transformation. Although existing studies in the literature discuss the relationship between biopolitics and foreign policy at the theoretical level (Ingram, 2013; Lakoff, 2017), the integrated analysis of these three economic domains and their long-term empirical examination constitute the original contribution of this research. The preparedness and emergency management concepts developed by Collier and Lakoff (2015) strengthen the theoretical framework of this research. First, the findings reveal that drug economies are positioned on a security-centered axis in states' foreign policy strategies. The transborder organizational structure of illicit drug trade has directed states toward establishing regional cooperation and strengthening international sanction mechanisms. This situation corresponds with the determinations emphasized by Passos (2023) and Snyder (2019) in the literature that military operations and counternarcotics policies have transformed into foreign policy priorities in Latin America. The effect of American foreign policy on drug wars in Latin America examined by Youngers and Rosin (2005) supports this finding. However, the findings of this study demonstrate that this securitization process is not specific only to Latin America but has emerged in similar forms in the Middle East, Balkans, and Southeast Asia as well. The studies by Thoumi (2002) and Page No. 52 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | Paoli and colleagues (2009) reveal the regional differences and global connections of drug economies. States' use of anti-drug agreements as diplomatic instruments is evaluated as a concrete manifestation of the health security paradigm explained by Elbe (2009) and Fidler (2004). The innocent bystander position of developing countries in drug wars analyzed by Keefer and Loayza (2010) further complicates this dynamic. On the other hand, limitations of international cooperation in the regulation of drug economies are also observed. The report on global illicit drug markets prepared by Reuter and Trautmann (2009) reveals the structural weaknesses of cooperation mechanisms. Particularly the sovereignty concerns of producer and transit countries lead them to resist external interventions and reduce the effectiveness of regulatory politics (White, 2014). Second, it has been determined that global normative pressure plays a prominent role in the regulation of tobacco economies. The harmonization of states' domestic regulations with international standards by the Framework Convention on Tobacco Control, which entered into force in 2005, demonstrates how biopolitical strategies are strengthened through multilateral agreements. This finding is consistent with the normative power of global tobacco control revealed in the studies of Wipfli (2015) and Lee and Collin (2006). The studies of Studlar (2002) and Mamudu and colleagues (2011) examine in detail the policy dynamics of tobacco control and global power relations. However, this research offers an original contribution to the literature by revealing that regional cooperation against tobacco smuggling plays a critical role in increasing the effectiveness of regulatory politics. Particularly the European Union's border security protocols and the regional coordination mechanisms of Middle Eastern countries demonstrate that foreign policy functions as an instrument supporting regulatory frameworks. The tobacco control in developing countries analyzed by Jha and Chaloupka (2000) illuminates the socioeconomic dimensions of these dynamics. Nevertheless, the lobbying activities and attempts to intervene in policy processes by multinational tobacco corporations carry the potential to constrain states' regulatory autonomy, as indicated in the studies of Gilmore and colleagues (2013), Milov (2019), and Grier (2023). The study by Collin and colleagues (2002) reveals the global strategies of the tobacco industry and its mechanisms of intervention in state policies. This contradictory situation makes evident the tension between strengthening biopolitical capacity and protecting economic interests. Third, although the conflict between multinational corporations' aggressive market expansion strategies and states' regulatory policies in alcohol economies is a frequently emphasized topic in the literature (Room et al., 2005), the findings of this study demonstrate that foreign policy plays an indirect but effective role in the regulation of the alcohol market. Particularly the connection of tax policies aimed at reducing alcohol consumption in European and Central Asian countries with trade agreements confirms the regulatory difficulties indicated in the studies of Room and colleagues (2005) and Österberg and Karlsson (2002). The history of alcohol policies in the United Kingdom examined by Nicholls (2009) provides an important perspective for understanding the social and economic context of regulatory politics. However, this research reveals that alcohol advertising bans and sales restrictions are shaped according to national health priorities rather than compliance with international Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org norms. This situation demonstrates that the global governance structures observed in tobacco and drug economies do not possess the same strength in the alcohol economy. The cultural dimension of nightlife and alcohol policies discussed by Measham and Østergaard (2019) emphasizes that local dynamics are determinative in states' regulatory preferences. This finding reveals that biopolitics requires context-specific strategies rather than a universal governance model. The global perspective on alcohol policy by Babor and Caetano (2010) explains this diversity. Fourth, the findings demonstrate that states' biopolitical capacities are strengthened not only through regulatory instruments but also through international diplomacy and soft power use. The concept of health diplomacy is defined as an instrument increasing states' international legitimacy in the studies of Kickbusch and colleagues (2016) and Davies (2010). The findings of this research reveal that this form of diplomacy produces concrete policy outcomes in drug, alcohol, and tobacco economies. The connections between global health and international relations explained by McInnes and Lee (2012) theoretically support this finding. Particularly the cooperation of developing countries with international health organizations offers strategic opportunities in terms of creating normative power and establishing regional leadership. This finding is consistent with the increasing role of developing countries in global health governance indicated in Aginam's (2005) study. The political dynamics of global health governance examined by Harman and Williams (2013) and Harman and Papamichail (2024) illuminate this process. However, effective use of health diplomacy requires the strengthening of states' institutional capacities. The institutional weaknesses emphasized by Fidler (2010) and Harman and Williams (2013) in the literature constrain the transformation of biopolitical strategies into foreign policy instruments. The partnership and governance mechanisms analyzed by Rushton and Williams (2011) and Youde (2012) demonstrate how these capacities can be developed. Fifth, the research reveals the differentiating effects of biopolitical interventions on gender and structural inequalities. Feminist international relations theories and critical political economy approaches emphasize that addictive substances cause more intensive harm in certain social segments. The findings of this study demonstrate that women and low-income groups in particular are disproportionately adversely affected by drug, alcohol, and tobacco economies. The violence, gender, and global health relationships examined by Klot and Nguyen (2011) reveal the multidimensional nature of these inequalities. This situation is evaluated as a concrete manifestation of the power relations over life and death explained by Mbembe's (2019) concept of necropolitics. The racial and gender-based biopolitical interventions discussed by Weheliye (2014) and Puar (2017) in the literature correspond with the findings of this research. Nguyen's (2010) study on AIDS treatment in West Africa demonstrates how biopolitical interventions are experienced in local communities. The potential of regulatory politics to deepen inequalities reveals the necessity of reevaluating biopolitical strategies from a social justice perspective. The care policies and colonial legacy analyzed by Ticktin (2011) and Raza Kolb (2020) provide a critical framework for this evaluation. Page No. 54 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | Sixth, the findings demonstrate that technological developments have transformed biopolitical capacities and rendered foreign policy strategies dependent on technical infrastructures. The use of artificial intelligence, big data analytics, and surveillance technologies in monitoring drug trafficking, tobacco, and alcohol consumption expands states' regulatory instruments. This situation is consistent with Haggerty and Ericson's (2006) surveillance society theses. The relationship between mental health and technology discussed by Rose (2019) explains the digitalization of biopolitics. However, this technological expansion carries the risk of strengthening the totalitarian dimensions of biopolitical control by narrowing the domains of freedom and privacy, as warned by Diken and Laustsen (2005). The technological dimension of mental health policies discussed by Rose (2019) in the literature is connected with the increasing use of digital instruments in addiction treatment. The relationship between counter-terrorism and biopolitics analyzed by Reid (2006) explains the legitimization of surveillance technologies. This finding reveals that biopolitics is a multilayered form of governance targeting not only physical life but also psychological and behavioral processes. The state of exception and bare life concepts conceptualized by Agamben (2005) constitute the philosophical foundation of this transformation. Seventh, the research demonstrates that neoliberal economic policies play a paradoxical role in the regulation of drug, alcohol, and tobacco economies. Neoliberalism, while advocating free market principles and constraining regulatory interventions on one hand, requires states to strengthen their biopolitical capacities on the other. This contradiction is consistent with the ambivalent nature of neoliberal governance discussed in Lemm and Vatter's (2014) studies based on Foucault's governmentality analyses. The relationship between governmentality and freedom developed by Dean (2010) explains this paradox. The findings reveal that tobacco and alcohol industries in particular weaken national regulations by benefiting from free trade agreements. This situation corresponds with the mechanisms of multinational corporations' intervention in policy processes indicated in the studies of Collin and colleagues (2002) and Mamudu and colleagues (2011). The global trade and social citizenship relationships analyzed by Shamir (2013) address this dynamic with a holistic perspective. On the other hand, states' market intervention through tax policies and advertising bans demonstrates that neoliberal discourse is limited in practice. The relationship between neoliberalism and biopolitics examined by Ayo (2012) theoretically frames this contradictory situation. Eighth, the findings reveal that the multi-actor structure of global health governance both increases and complicates the effectiveness of biopolitical strategies. Governance networks where states, international organizations, civil society organizations, and private sector actors coexist lead to regulatory politics assuming a multidimensional character. This situation is consistent with the fragmented structure of global health governance discussed in the studies of Rushton and Williams (2011) and Youde (2012). The analyses of Hein and colleagues (2007) on AIDS combat and global health governance illuminate the dynamics of the multiactor structure. However, this research demonstrates that the multi-actor structure leads to coordination problems and creates tension between national sovereignty and international normative pressure. Particularly the difficulties experienced by developing countries in Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org complying with policy recommendations of international organizations reflect the unequal distribution of biopolitical capacities. The global health inequalities and health effects of globalization emphasized by Labonté and Gagnon (2010) and Kawachi and Wamala (2007) support these findings. The global health inequalities emphasized in Labonté and Gagnon's (2010) study in the literature support these findings. The global health security and justice mechanisms analyzed by Rushton and Youde (2014) and Ruger (2018) provide a framework for addressing inequalities. Ninth, the research reveals that biopolitics is not merely an instrument of threat management in foreign policy but also a domain creating opportunities for economic development and cultural interaction. States' health-based diplomacy strategies strengthen international cooperation mechanisms and support regional integration. This finding corresponds with the multifaceted structure of health diplomacy discussed in McInnes and Lee's (2012) study on global health and international relations. The conceptual framework between health, foreign policy, and security developed by Ingram (2004) explains this integrated structure. However, effective use of health diplomacy requires the strengthening of states' normative leadership capacities. The conceptual connections between health and security indicated in Ingram's (2004) study in the literature facilitate the positioning of biopolitics as a strategic instrument in foreign policy. The health security and virus politics analyzed by Elbe (2009, 2010) provide concrete examples of this strategic positioning. Nevertheless, it is observed that the effectiveness of health diplomacy increases in situations where it overlaps with economic and security interests. The relationship between global politics and health examined by Davies (2010) addresses this overlap in detail. Tenth, the findings demonstrate that drug, alcohol, and tobacco economies have transformed states' sovereignty capacities and redefined the national-transnational duality. Sassen's (2006) analyses of territory, authority, and rights relationships provide a convenient framework for explaining this transformation. Globalization processes require states to restructure their sovereignty practices both within national borders and at the transnational level. The global population, environment, and political power relationships examined by Bashford (2014) and Connelly (2008) demonstrate the historical depth of this restructuring. The findings of this research reveal that regulatory politics is shaped by compliance with international norms, yet states' concern for protecting national interests does not narrow sovereignty domains. This situation is consistent with the strategies of modern states strengthening their biopolitical capacities through transnational mechanisms discussed in Elden's (2016) study on sovereignty and territory relationships. The biosecurity and preparedness concepts developed by Collier and Lakoff (2015) concretize these strategies. On the other hand, the constraint of national policymaking autonomy by international pressures revives sovereignty debates. The health governance, security, and boundaries of biopolitics analyzed by Ingram (2013) deepen these debates. Eleventh, the research demonstrates that the legitimacy foundations of biopolitical interventions have changed and that health-based justifications have become integrated with security and economic discourses. States' legitimization of their regulations regarding drug, Page No. 56 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | alcohol, and tobacco economies with the aim of protecting public health simultaneously provides international cooperation and diplomatic advantage. This finding is connected with the processes of biopolitical interventions gaining legitimacy explained by Agamben's (2005) concepts of state of exception and bare life. The liberal war and biopolitics relationship developed by Dillon (2008) and Dillon and Reid (2009) explains these legitimacy processes. The relationship between counter-terrorism and biopolitics discussed in Reid's (2006) study in the literature demonstrates how security discourses shape health policies. However, this research reveals that when health justifications combine with security discourses, they facilitate states' use of extraordinary powers. The unpreparedness and emergency management examined by Lakoff (2017) demonstrates the normalization of these extraordinary powers. This situation emphasizes the necessity of balancing biopolitical strategies with democratic oversight mechanisms. The cultural perceptions and biopolitics analyzed by Nichter (2008) illuminate the social dimension of legitimacy processes. Twelfth, the findings demonstrate that border security and smuggling control are among the fundamental domains where biopolitical strategies materialize. Particularly cross-border operations and joint intelligence sharing developed against drug and tobacco smuggling position states' foreign policy cooperation on a security-centered axis. This finding is consistent with how the connections among crime, corruption, and terrorism shape states' security strategies discussed in Shelley's (2014) study. The illicit trade and global economy relationships analyzed by Naim (2005) reveal the transnational dimensions of smuggling. The analyses of organized crime and state formation in post-Soviet Eurasia by Kupatadze (2014) in the literature support the findings of this research. However, the strengthening of border security leads to illicit trade shifting to new routes and constrains the effectiveness of regulatory politics. The global illicit drug markets and public interest analyses by Reuter and colleagues (2009, 2015) demonstrate this dynamic. This situation reflects the complex and multilayered nature of biopolitical interventions. The policing and international crime control examined by Andreas (2009) and Andreas and Nadelmann (2006) explain the historical development of border security. Thirteenth, the research reveals that biopolitics is a form of power that governs not only life but also death. Mbembe's (2019) concept of necropolitics explains states' authority to decide which lives are worth protecting. The findings of this research demonstrate that the social costs of drug wars in particular concentrate in certain segments and that states' regulatory strategies can transform into structural violence. The bare life and state of exception conceptualized by Agamben (2005) constitute the theoretical foundation of necropolitical practices. The analyses of drug wars and the global color line by Koram (2019) in the literature support this finding. However, this research reveals that necropolitical practices are not limited only to military operations; regulatory policies also reduce the life chances of certain groups. The racial subjectivity and right to maim concepts developed by Weheliye (2014) and Puar (2017) explain the structural dimensions of these practices. This situation emphasizes the necessity of reevaluating the ethical dimension of biopolitical strategies. The republic of therapy and sovereignty relationships examined by Nguyen (2010) demonstrate the manifestations of necropolitics in the health domain. Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org Fourteenth, the findings demonstrate that global trade regimes play a determinative role in the regulation of drug, alcohol, and tobacco economies. Free trade agreements and World Trade Organization norms constrain states' regulatory autonomy and compel them to balance national health policies with economic interests. This situation is consistent with Shamir's (2013) study on global trade, human rights, and social citizenship relationships. The global tobacco industry and trade agreements analyzed by Collin (2012) provide concrete examples of these constraints. The analyses of policy dynamics of tobacco control by Studlar (2002) in the literature demonstrate how trade regimes affect regulatory processes. However, this research reveals that some states protect their regulatory domains by including health provisions in trade agreements. The study on global tobacco control, power, and governance by Mamudu and colleagues (2011) details these protection mechanisms. This finding demonstrates that states' capacities to resist international economic pressures differ. The study by Gilmore and colleagues (2013) reveals how industrial lobbying activities affect state capacities. Fifteenth, the research reveals that the long-term effectiveness of biopolitical strategies depends on institutional capacity and social acceptance. States' ability to implement regulatory policies requires the existence of strong institutional structures and social legitimacy. This finding is connected with the power and subject relationship discussed in Dean's (2010) study on governmentality and social regulation. The government of life, Foucault, biopolitics, and neoliberalism analyzed by Lemm and Vatter (2014) deepen this relationship. The preparedness concept by Collier and Lakoff (2015) in the literature emphasizes that states' risk management capacities are grounded in institutional infrastructure. However, this research demonstrates that social resistance constrains the effectiveness of biopolitical interventions and that regulatory policies need to be adapted to cultural contexts. The cultural perceptions, social representations, and biopolitics examined by Nichter (2008) emphasize the importance of this adaptation. This situation reveals that biopolitics requires context-specific strategies rather than a universal model. The globalization and health relationship analyzed by Kawachi and Wamala (2007) demonstrates contextual diversity. Sixteenth, the findings demonstrate that drug, alcohol, and tobacco economies carry different priorities in foreign policy, yet all are instruments strengthening biopolitical capacity. While drug economies are addressed with a security-centered approach (Passos, 2023; White, 2014), tobacco economies are regulated through normative pressure and international agreements (Wipfli, 2015), and alcohol economies are shaped more according to national priorities (Room et al., 2005). This differentiation demonstrates that states adapt their biopolitical strategies according to foreign policy objectives. The international drug policy examined by Hayle (2024) reveals the global dimensions of the security-centered approach. The cultural perceptions, social representations, and biopolitics study by Nichter (2008) in the literature supports this finding. However, the common point of the three economic domains is that all of them transform states' sovereignty capacities and reshape international relations. The transnational structure of the tobacco economy analyzed by Lee and Collin (2006) and Milov (2019) exemplifies this transformation. This situation reflects the multidimensional nature of Page No. 58 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | biopolitics. The health security and foreign policy frameworks developed by Elbe (2009, 2010), Fidler (2004, 2010), and McInnes and Lee (2012) explain this multidimensionality. Seventeenth, the research reveals that the public health outcomes of biopolitical interventions are complex and contradictory. While regulatory policies achieve success in reducing tobacco use and alcohol consumption on one hand (Jha & Chaloupka, 2000; Österberg & Karlsson, 2002), the criminalization of illicit drug use increases social harms on the other. This situation emphasizes the importance of harm reduction approaches discussed in Reuter and Majmundar's (2015) study on drug policy and public interest in the literature. The effects of drug policies in developing countries analyzed by Keefer and Loayza (2010) and Youngers and Rosin (2005) detail these contradictory outcomes. The findings demonstrate that biopolitical strategies must take into account not only health costs but also social inequalities and structural violence. The drug wars and global color line examined by Koram (2019) reveal the dimensions of structural violence. This situation reveals policymakers' obligation to establish a balance among health, security, and justice. The global health justice and governance framework developed by Ruger (2018) demonstrates how this balance can be established. Eighteenth, the findings demonstrate that future biopolitical strategies need to be integrated with global processes such as climate change, migration movements, and digital transformation. The regulation of drug, alcohol, and tobacco economies must be integrated not only with health policies but also with environmental sustainability and social justice perspectives. This finding is consistent with the increasing role of environmental risks in health governance discussed in Bashford's (2014) study on global population, environment, and biopolitics. The population, political power, and state relationships analyzed by Connelly (2008) demonstrate the historical and structural dimensions of this integration. The population, political power, and state analyses by Connelly (2008) in the literature emphasize the multidimensional nature of biopolitics. However, this research reveals that future policy recommendations need to be supported by interdisciplinary approaches. The globalization, health, and environment relationships examined by Kawachi and Wamala (2007) and Bashford (2014) emphasize the necessity of an interdisciplinary approach. This situation demonstrates that biopolitics is a complex domain requiring the joint effort not only of health sciences but also of social sciences, law, and international relations. The global health security, governance, and partnership frameworks developed by Rushton and Youde (2014), Harman and Williams (2013), and Youde (2012) demonstrate how this joint effort can be organized. Nineteenth, the research reveals that the strengthening of biopolitical capacities needs to be supported by democratic participation and accountability mechanisms. The legitimacy of states' regulatory policies is directly related to social acceptance. This finding supports the importance of participatory approaches emphasized in Ruger's (2018) study on global health justice and governance. The partnerships and governance mechanisms analyzed by Rushton and Williams (2011) demonstrate how democratic participation can be strengthened. The analyses of humanitarian policies and care relationships by Ticktin (2011) in the literature Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org emphasize the ethical dimension of biopolitical interventions. However, this research demonstrates that in authoritarian regimes in particular, biopolitical strategies are implemented devoid of democratic oversight. The state of exception and liberal modernity discussed by Agamben (2005) and Reid (2006) explain the legitimization of authoritarian practices. This situation reveals the necessity of protecting human rights and freedoms in global health governance. The health governance, security, and boundaries of biopolitics examined by Ingram (2013) provide a critical perspective for protecting human rights. Twentieth, the findings demonstrate that biopolitics will continue to play a central role in future foreign policy strategies. The increasing frequency of global health crises is increasing the need for states to strengthen their biopolitical capacities and activate international cooperation mechanisms. This finding is consistent with the risk management strategies discussed in Lakoff's (2017) preparedness concept and Rushton and Youde's (2014) global health security studies. The biosecurity and emergency preparedness concepts developed by Collier and Lakoff (2015) constitute the foundation of future strategies. The global health governance and AIDS combat analyses by Hein and colleagues (2007) in the literature emphasize the importance of international cooperation. However, this research reveals that the effectiveness of biopolitical strategies depends on states' institutional capacities and international solidarity. The health diplomacy and global health governance studies by Fidler (2004, 2010) and Kickbusch and colleagues (2016) demonstrate how institutional capacity and solidarity can be strengthened. This situation emphasizes the necessity of grounding future policy recommendations in the principles of equality, justice, and sustainability. The global health governance, international relations, and partnership mechanisms analyzed by Harman and Williams (2013), McInnes and Lee (2012), and Youde (2012) provide a roadmap for how these principles can be implemented. 7. CONCLUSION AND RECOMMENDATIONS This research has demonstrated that drug, alcohol, and tobacco economies transformed states' biopolitical capacity during the period 1981–2025 and that this transformation played a determinative role in the restructuring of foreign policy strategies. The findings demonstrate that health security has become a strategic domain transcending national borders; that states' population management, risk control, and international cooperation practices are shaped in close interaction with global governance mechanisms. This interaction parallels the expansion of the security concept from military threats toward human security issues in the post-Cold War period (Elbe, 2009, 2010; Fidler, 2004). The study presents an original analytical framework by integrating the concepts of biopolitics, regulatory politics, and foreign policy, which are generally addressed by separate disciplines in the literature; rendering visible the common structural characteristics and reciprocal interactions of drug, alcohol, and tobacco economies. This integrated perspective provides a critical foundation for understanding how states' modes of governing social life are reproduced at both national and global levels (Foucault, 2003, 2008; Sassen, 2006; Ingram, 2013). Particularly the penetration of neoliberal governmentality understanding into global health policies has required states to align their regulatory capacities with market rationality, and this process has accelerated the Page No. 60 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | transformation of sovereignty practices as explained in the analyses of Lemm and Vatter (2014) and Elden (2016). The first of the fundamental contributions of the research is that the joint examination of these three economies transcends the fragmented approaches in the literature and reveals the multidimensional nature of states' biopolitical strategies. The transformation of the drug economy into a security-centered foreign policy instrument, the regulation of the tobacco economy under global normative pressure, and the shaping of the alcohol economy along the axis of cultural-economic interests demonstrate that all three domains are governed with different biopolitical logics. However, the common point is that all three have transformed states' sovereignty capacities and redefined international relations (Bewley-Taylor & Jelsma, 2012; Wipfli, 2015; Room et al., 2005). The international drug policy research of BewleyTaylor and Tinasti (2020) and Collins's (2021) analyses on the legalization of the drug war reveal the paradigmatic shift of this transformation. Second, the study reveals that neoliberal globalization processes have rendered states' regulatory instruments dependent on international norms; yet this dependence is balanced with the concern for protecting national interests. Esposito's (2008, 2011, 2013) studies on biopolitics and immunity concepts constitute the theoretical foundation of this search for balance. The norm-producing role of transnational actors such as the World Health Organization, World Trade Organization, and United Nations strengthens states' biopolitical capacities while simultaneously narrowing sovereignty domains (Labonté & Gagnon, 2010; Youde, 2012). The comprehensive analyses of Kawachi and Wamala (2007) on the relationship between globalization and health demonstrate how trade agreements constrain health policies. Third, the research demonstrates that health diplomacy has become a strategic instrument for states in increasing their soft power capacities. Health-based foreign policy approaches confer international legitimacy upon states and provide normative leadership position (Kickbusch et al., 2016; McInnes & Lee, 2012). Davies's (2010) study on global politics and health and Harman and Williams's (2013) analyses of global health governance present the counterpart of this strategic transformation in international relations theory. The findings demonstrate that drug trade directly determines states' security strategies with its illicit economic volume exceeding five hundred billion dollars annually (UNODC, 2022). Particularly the control of drug routes in Latin America, Central Asia, and the Balkans plays a central role in the shaping of regional stability and international alliances (Paoli et al., 2009; Kupatadze, 2014; Gootenberg, 2008). The global illicit drug markets report of Reuter and Trautmann (2009) and the illicit global economy analyses of Friman and Andreas (1999) detail the pressure of this economic volume on state structures. The United States' war on drugs strategy, the European Union's harm reduction policies, and Asian countries' zero tolerance approaches concretize how different biopolitical positionings shape foreign policy preferences. The study on drugs and democracy in Latin America by Youngers and Rosin (2005), the analysis of military operations and counter-narcotics policies by Passos (2023), and the research on coca-cocaine commodity chain governance by Snyder (2019) reveal the regional effects of these different approaches. This differentiation strengthens the fragmented structure of global health governance and deepens international coordination problems Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org Bilir, N., Özcebe, H., Ergüder, T., & Mauer-Stender, K. (2012). Tobacco control in Turkey: Story of commitment and leadership. World Health Organization Regional Office for Europe. Boiteux, L. (2015). Brazil: Critical reflections on a repressive drug policy. Sur Journal, 12(21), 7 s. Bone, M. L. (2020). Human rights and drug control: A new perspective. Routledge. Buxton, J. (2006). The political economy of narcotics: Production, consumption and global markets. Zed Books. Carpenter, T. G. (2003). Bad neighbor policy: Washington's futile war on drugs in Latin America. Palgrave Macmillan. Casswell, S., & Thamarangsi, T. (2009). Alcohol policies in developing societies. World Health Organization. Chatwin, C. (2018). Towards more effective global drug policies. Palgrave Macmillan. Chepesiuk, R. (1999). War on drugs: An international encyclopedia. ABC-CLIO. Clough, P. T., & Willse, C. (Eds.). (2011). Beyond biopolitics: Essays on the governance of life and death. Duke University Press. Collier, S. J., & Lakoff, A. (2015). Vital systems security: Reflexive biopolitics and the government of emergency. Theory, Culture & Society. Collin, J. (2012). Tobacco control, global health policy, and development: Towards policy coherence in global governance. Tobacco Control. Collin, J., Lee, K., & Bissell, K. (2002). The framework convention on tobacco control: The politics of global health governance. Third World Quarterly. Collins, J. (Ed.). (2016). Ending the war on drugs: Global health and human rights in drug policy reform. Routledge. Collins, J. (2021). Legalising the drug wars: A regulatory history of UN drug control. Cambridge University Press. Collins, J. (2021). Legalising the drug war? The transformation of international drug control. Cambridge University Press. Connelly, M. (2008). Fatal misconception: The struggle to control world population. Harvard University Press. Page No. 68 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | Creswell, J. W., & Plano Clark, V. L. (2018). Designing and conducting mixed methods research (3rd ed.). SAGE Publications. Davies, S. E. (2010). Global politics of health. Polity Press. de Beyer, J., & Waverley Brigden, L. (Eds.). (2003). Tobacco control policy: Strategies, successes, and setbacks. World Bank. Dean, M. (2010). Governmentality: Power and rule in modern society (2nd ed.). SAGE Publications. Derthick, M. (2011). Up in smoke: From legislation to litigation in tobacco politics (3rd ed.). CQ Press. Diken, B., & Laustsen, C. B. (2005). The culture of exception: Sociology facing the camp. Routledge. Dillon, M. (2015). Biopolitics of security: A political analytic of finitude. Routledge. Dillon, M., & Reid, J. (2009). The liberal way of war: Killing to make life live. Routledge. Ditrych, O., & Sánchez Avilés, C. (2023). Governing human life: (Bio)politics, knowledge and borders in global drug policy. Palgrave Macmillan. Drope, J. (Ed.). (2011). Tobacco control in Africa: People, politics and policies. Anthem Press / IDRC. Dutta, S. (Ed.). (2019). Confronting illicit tobacco trade: A global review of country experiences. World Bank / World Bank Group Tobacco Control Program. Eastwood, N., Fox, E., & Rosmarin, A. (2016). A quiet revolution: Drug decriminalisation policies in practice across the globe. Release. Eisner, M. A. (2017). Regulatory politics in an age of polarization and drift: Beyond deregulation. Routledge. Elbe, S. (2009). Virus alert: Security, governmentality, and the AIDS pandemic. Columbia University Press. Elbe, S. (2010). Security and global health. Polity Press. Elden, S. (2016). Foucault's last decade. Polity Press. Esposito, R. (2008). Bíos: Biopolitics and philosophy. University of Minnesota Press. Esposito, R. (2011). Immunitas: The protection and negation of life. Polity Press. Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org Esposito, R. (2013). Terms of the political: Community, immunity, biopolitics. Fordham University Press. Farmer, P. (2005). Pathologies of power: Health, human rights, and the new war on the poor. University of California Press. Felbab-Brown, V. (2010). Shooting up: Counterinsurgency and the war on drugs. Brookings Institution Press. Fidler, D. P. (2004). SARS, governance and the globalization of disease. Palgrave Macmillan. Fidler, D. P. (2010). The challenges of global health governance. Council on Foreign Relations. Foucault, M. (2003). "Society must be defended": Lectures at the Collège de France, 1975– 1976. Picador. Foucault, M. (2007). Security, territory, population: Lectures at the Collège de France, 1977–1978. Palgrave Macmillan. Foucault, M. (2008). The birth of biopolitics: Lectures at the Collège de France, 1978–1979. Palgrave Macmillan. Friman, H. R., & Andreas, P. (Eds.). (1999). The illicit global economy and state power. Rowman & Littlefield. Gilmore, A. B., Fooks, G., & McKee, M. (2011). A review of the impacts of tobacco industry privatisation: Implications for policy. Global Public Health, 6(6), 621-642. Gilmore, A., Fooks, G., & McKee, M. (Eds.). (2013). Exposing and addressing tobacco industry tactics in Europe. World Health Organization Regional Office for Europe. Gingeras, R. (2014). Heroin, organized crime, and the making of modern Turkey. Oxford University Press. Gootenberg, P. (2008). Andean cocaine: The making of a global drug. University of North Carolina Press. Grier, J. (2023). The New Prohibition: The Dangerous Politics of Tobacco Control. Jacob Grier. Gutierrez, E. D. U. (2023). Rethinking illicit economies in opium and cocaine: Policy responses to drug crops in the global South. Routledge. https://doi.org/10.4324/9781003396642 Page No. 70 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | Haggerty, K. D., & Ericson, R. V. (2006). The new politics of surveillance and visibility. University of Toronto Press. Harman, S., & Papamichail, A. (2018). Global health governance. Routledge. Harman, S., & Papamichail, A. (2020). Global health governance. Routledge. Harman, S., & Papamichail, A. (2024). Global health governance. Routledge. Harman, S., & Williams, D. (2013). Global health governance: Power, policy and politics. Palgrave Macmillan. Hayle, S. (2024). International drug policy. Palgrave Macmillan. Hein, W., Bartsch, S., & Kohlmorgen, L. (Eds.). (2007). Global health governance and the fight against HIV/AIDS. Palgrave Macmillan. Ingram, A. (Ed.). (2004). Health, foreign policy and security: Towards a conceptual framework for research and policy. Nuffield Trust. Ingram, A. (2013). Health governance, security and the limits of biopolitics. Routledge. Jha, P., & Chaloupka, F. (Eds.). (2000). Tobacco control in developing countries. Oxford University Press. Joossens, L., Merriman, D., Ross, H., & Raw, M. (2010). The impact of eliminating the global illicit cigarette trade on health and revenue. Addiction, 105(9), 1640–1649. https://doi.org/10.1111/j.1360-0443.2010.03002.x Joossens, L., & Raw, M. (2008). Progress in combating cigarette smuggling: Controlling the supply chain. Tobacco Control. Kanazawa, R. (2023). Boundaries of addiction, treatment and disease: Global drugs governance from post-war to AIDS. McGill-Queen’s University Press. Kawachi, I., & Wamala, S. P. (Eds.). (2007). Globalization and health. Oxford University Press. Keefer, P., & Loayza, N. (Eds.). (2010). Innocent bystanders: Developing countries and the war on drugs. World Bank. Kickbusch, I., Allen, L., & Franz, C. (2016). Global health diplomacy: Concepts, issues, actors, instruments, fora and cases. Springer. Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org Klot, J. F., & Nguyen, V.-K. (Eds.). (2011). The fourth wave: Violence, gender, culture and HIV in the 21st century. UNESCO; Social Science Research Council. Koram, K. (Ed.). (2019). The war on drugs and the global colour line. Pluto Press. Kupatadze, A. (2014). Organized crime, political transitions and state formation in postSoviet Eurasia. Palgrave Macmillan. Labonté, R., & Gagnon, M. L. (2010). Globalization and health equity in global health governance. Routledge. Lakoff, A. (2017). Unprepared: Global health in a time of emergency. University of California Press. Lee, K., & Collin, J. (2006). Global change and transnational tobacco. Palgrave Macmillan. Lemm, V., & Vatter, M. (Eds.). (2014). The government of life: Foucault, biopolitics, and neoliberalism. Fordham University Press. Levi-Faur, D., & Benish, A. (Eds.). (2020). The rise of the regulatory welfare state: The use and abuse of social regulation (Vol. 691). The ANNALS of the American Academy of Political and Social Science. Mamudu, H. M., Hammond, R., & Glantz, S. A. (2011). Global tobacco control: Power, policy, governance and transfer. Palgrave Macmillan. Mbembe, A. (2019). Necropolitics. Duke University Press. McInnes, C., & Lee, K. (2012). Global health and international relations. Polity Press. McInnes, C., Kamradt-Scott, A., Lee, K., Reubi, D., Roemer-Mahler, A., Rushton, S., & Williams, O. D. (2015). The transformation of global health governance. Palgrave Macmillan. Measham, F., & Østergaard, J. (Eds.). (2019). Nightlife and alcohol: Policy, practice and perspectives. Routledge. Milov, S. (2019). The cigarette: A political history. Harvard University Press. Naim, M. (2005). Illicit: How smugglers, traffickers, and copycats are hijacking the global economy. Doubleday. Nguyen, V.-K. (2010). The republic of therapy: Triage and sovereignty in West Africa's time of AIDS. Duke University Press. Page No. 72 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | Nicholls, J. (2009). The politics of alcohol: A history of the drink question in England. Manchester University Press. Nichter, M. (2008). Global health: Why cultural perceptions, social representations, and biopolitics matter. University of Arizona Press. OECD, & European Observatory on Health Systems and Policies. (2024). Strengthening health systems: A practical handbook for resilience testing. OECD Publishing. https://doi.org/10.1787/3a39921e-en Österberg, E., & Karlsson, T. (Eds.). (2002). Alcohol policies in EU member states and Norway. Nordic Council for Alcohol and Drug Research. Paoli, L., Greenfield, V. A., & Reuter, P. (2009). The world heroin market: Can supply be cut? Oxford University Press. Passos, A. M. (2023). Democracies at war against drugs: Military operations and counternarcotics policies in Latin America. Palgrave Macmillan. Puar, J. K. (2017). The right to maim: Debility, capacity, disability. Duke University Press. Raza Kolb, A. F. (2020). Epidemic empire: Colonialism, contagion, and terrorism, 1817– 2020. University of Chicago Press. Rehm, J., Mathers, C., Popova, S., Thavorncharoensap, M., Teerawattananon, Y., & Patra, J. (2009). Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. The Lancet. Reid, J. (2006). The biopolitics of the war on terror: Life struggles, liberal modernity and the state of exception. Manchester University Press. Reuter, P., & Majmundar, M. K. (Eds.). (2015). Drug policy and the public good (2nd ed.). Oxford University Press. Reuter, P., & Trautmann, F. (Eds.). (2009). A report on global illicit drug markets 1998– 2007. European Commission; RAND Corporation. Room, R., Babor, T., & Rehm, J. (2005). Alcohol and public policy. Oxford University Press. Rose, N. (2019). Our psychiatric future: The politics of mental health. Polity Press. Ruger, J. P. (2018). Global health justice and governance. Oxford University Press. Rushton, S., & Williams, O. D. (Eds.). (2011). Partnerships and foundations in global health governance. Palgrave Macmillan. Arslan, S. (2025). BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025). GPH-International Journal of Health Sciences and Nursing, 8(2), 23-77. https://doi.org/10.5281/zenodo.17812801 © (GPH-IJHSN) | Vol. 8, Issue 02, (July-December 2025) | Open Access | www.gphjournal.org Rushton, S., & Youde, J. (Eds.). (2014). Routledge handbook of global health security. Routledge. Sassen, S. (2006). Territory, authority, rights: From medieval to global assemblages. Princeton University Press. Seddon, T. (2023). Rethinking drug laws: Theory, history, politics. Oxford University Press. Shamir, R. (2013). Current flows: Global trade, human rights and the re-making of social citizenship. Stanford University Press. Shelley, L. I. (2014). Dirty entanglements: Corruption, crime, and terrorism. Cambridge University Press. Snyder, R. (2019). Governing the coca-cocaine commodity chain: Drug politics in the Andes. Cambridge University Press. Studlar, D. T. (2002). Tobacco control: The policy dynamics of a regulatory challenge. Ashgate. TEPAV Tobacco Control Policy Research Team. (2020). The economics of curbing smoking in Turkey: A scoping review – Supply, demand, health, and public policy aspects. TEPAV. Thomas, S., & Fleming, P. (Eds.). (2024). Handbook of health system resilience. Edward Elgar Publishing. https://doi.org/10.4337/9781803925936 Thoumi, F. E. (2002). Illegal drugs, economy, and society in the Andes. Woodrow Wilson Center Press. Ticktin, M. (2011). Casualties of care: Immigration and the politics of humanitarianism in France. University of California Press. Tosza, S., & Vervaele, J. A. E. (Eds.). (2022). Combatting illicit trade in tobacco products: In search of optimal enforcement. Springer United Nations Development Programme. (2025). Development dimensions of drug policy. United Nations Development Programme. https://www.undp.org/sites/g/files/zskgke326/files/2025-09/undp-developmentdimensions-of-drug-policy.pdf United Nations Office on Drugs and Crime. (2020). World drug report 2020: Drug supply (Booklet 3). United Nations. UNODC. (2022). World drug report 2022. United Nations Office on Drugs and Crime. Page No. 74 BIOPOLITICS, REGULATORY POLITICS, AND FOREIGN POLICY: PUBLIC HEALTH IMPACTS OF DRUG, ALCOHOL, AND TOBACCO ECONOMIES (1981-2025) GPH-International Journal of Health Sciences and Nursing (GPH-IJHSN) | © 2025 | Open Access | Weheliye, A. G. (2014). Habeas viscus: Racializing assemblages, biopolitics, and black feminist theories of the human. Duke University Press. White, R. (2014). The war on drugs in the Americas. Routledge. WHO. (2018). WHO report on the global tobacco epidemic, 2018. World Health Organization. WHO. (2021). WHO report on the global tobacco epidemic, 2021. World Health Organization. Wipfli, H. (2015). The global war on tobacco: Mapping the world's first public health treaty. Johns Hopkins University Press. Wisehart, D. (2019). Drug control and international law. Routledge. World Health Organization. (2022). Invisible numbers: The true extent of noncommunicable diseases and what to do about them. World Health Organization. World Health Organization. (2024). Global status report on alcohol and health and treatment of substance use disorders. World Health Organization. Youde, J. (2012). Global health governance. Polity Press. Youngers, C. A., & Rosin, E. (Eds.). (2005). Drugs and democracy in Latin America: The impact of U.S. policy. Lynne Rienner. Page No. 77